Nontuberculous mycobacterial infections

Medical Clinics of North America

Volumn 81, Issue 2, 1997, Pages 361-379

  French, A L ^a   Benator, D A ^a   Gordin, F M ^a  

^a Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BCG VACCINE; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; DOXYCYCLINE; ETHAMBUTOL; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMIPENEM; IMMUNOMODULATING AGENT; INTERLEUKIN 2; ISONIAZID; MACROLIDE; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIUM CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; LIVER TOXICITY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

EID: 0030947084     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70522-8     Document Type: Article

References (84)

1. C.H. Ahn R.J. Wallace L.C. Steele Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii Am Rev Respir Dis 135 1987 10
2. V. Ausina J. Barrio M. Luquin Mycobacterium xenopi infections in the acquired immunodeficiency syndrome Ann Intern Med 109 1988 927
3. D.M. Bamberger M.R. Driks M.R. Gupta Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City Clin Infect Dis 18 1994 395
4. T.W. Barber D.E. Craven H.W. Farber Mycobacterium gordonae : A possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection Chest 100 1991 716
5. C.A. Benson Mycobacterium avium complex disease in patients with AIDS Infect Dis Clin Pract 1 1995 1
6. 3. In Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, 1996, p 91
7. C.A. Benson J.J. Ellner Mycobacterium avium complex infection and AIDS: Advances in theory and practice Clin Infect Dis 17 1993 7
8. G.A. Bergen B.G. Yangco H.M. Adelham Central nervous system infection with Mycobacterium kansasii Ann Intern Med 118 1993 396
9. L.E. Bermudez M. Petofsky P. Kolonoski An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract J Infect Dis 165 1992 75
10. M.T. Bessesen J. Shlay B. Stone-Venohr Disseminated Mycobacterium genavense infection: Clinical and microbiological features and response to therapy AIDS 7 1993 1357
11. Blinkhorn R: Clarithromycin and ethambutol synergy against clarithromycin-resistant M. avium complex isolates. In Abstracts of the 1996 International Conference of the American Thoracic Society, New Orleans, 1996, p A329
12. S.T. Brown F.F. Edwards E.M. Bernard Progressive disseminated infections with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine treated rats J Infect Dis 164 1991 922
13. Burman W, Morgan M, Stone B, et al: Apparent transient Mycobacterium avium bacteremia: Incidence, laboratory features and clinical correlates. In Program and Abstract of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996, p 85
14. W.R. Butler S.P. O'Connor M.A. Yakrus Mycobacterium celatum sp. nov Int J Syst Bacteriol 43 1993 539
15. CDC Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome MMWR 36 1987 3S
16. R.E. Chaisson C.A. Benson M.P. Dube Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: A randomized, double-blind, dose-ranging study in patients with AIDS Ann Intern Med 121 1994 905
17. Chaisson RE, Keiser P, Pierce M, et al: Controlled trial of clarithromycin/ethambutol with or without clofazamine for Mycobacterium avium bacteremia in AIDS. In Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, 1996, p 164
18. R.E. Chaisson R.D. Moore D.D. Richman Incidence and natural history of Mycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine Am Rev Respir Dis 146 1992 285
19. J. Chan J.C. McKitrick R.S. Klein Mycobacterium gordonae in the acquired immunodeficiency syndrome Ann Intern Med 101 1984 400
20. D.P. Chin P.C. Hopewell D.M. Yajko Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection J Infect Dis 169 1994 289
21. D.P. Chin A. Reingold E.N. Stone The impact of Mycobacterium avium bacteremia and its treatment on survival in AIDS patients—a prospective study J Infect Dis 170 1994 578
22. M.G. Connolly R.P. Baughman M.N. Dohn Mycobacterium kansasii presenting as an endobronchial lesion Am Rev Respir Dis 148 1993 1405
23. B. Dautzenberg C. Truffot S. Legris Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome Am Rev Respir Dis 144 1991 564
24. E. Delaporte S. Alfandari F. Piette Mycobacterium ulcerans associated with infection due to the human immunodeficiency virus Clin Infect Dis 18 1994 1839
25. L.L. Dever J.W. Martin B. Seaworth Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS Clin Infect Dis 14 1992 1195
26. A. Eichmann A. Huszar A. Bon Mycobacterium chelonae infection of lymph nodes in an HIV-infected patient Dermatology 187 1993 299 300
27. R.H.K. Eng C. Forrester S.M. Smith Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome Chest 86 1984 145
28. A.W. Friedman R.W. Ike Mycobacterium kansasii septic arthritis in a patient with acquired immune deficiency syndrome Arthritis Rheum 36 1993 1631
29. J.B. Greene G.S. Sidhu S. Lewin Mycobacterium avium-intracellulare : A cause of disseminated life-threatening infection in homosexuals and drug abusers Ann Intern Med 97 1982 539
30. L.S. Guthertz B. Damsker E.J. Bottone Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS J Infect Dis 160 1989 1037
31. J.A. Havlik C.R. Horsburgh B. Metxhock Disseminated Mycobacterium avium complex infection: Clinical identification and epidemiologic trends J Infect Dis 165 1992 577
32. D. Havlir F. Torriani M. Dube Uveitis associated with rifabutin prophylaxis Ann Intern Med 121 1994 510
33. D.V. Havlir M.P. Dube F.R. Sattler Prophylaxis against disseminated Mycobacterium avium compex with weekly azithromycin, daily rifabutin, or both N Engl J Med 335 1996 392
34. C.C. Hawkins J.W.M. Gold E. Whimbey Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome Ann Intern Med 105 1986 184
35. L.B. Heifits N. Mor J. Vanderkolk Mycobacterium avium strains resistant to clarithromycin and azithromycin Antimicrob Agents Chemother 37 1993 2364
36. B. Hirschel H.R. Chang N. Mach Fatal infection with a novel unidentified Mycobacterium in a man with the acquired immunodeficiency syndrome N Engl J Med 323 1990 109
37. S.M. Holland E.M. Eisenstein D.B. Kuhns Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma, a preliminary report N Engl J Med 330 1994 1348
38. D.R. Hoover A.J. Saah H. Bacellar Clinical manifestations of AIDS in the era of pneumocystis prophylaxis N Engl J Med 329 1993 1922
39. C.R. Horsburgh D.P. Chin D.M. Yajko Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection J Infect Dis 170 1994 362
40. Horsburgh CR, Hanson DL, Thompson SE: Decreased risk of disseminated M. avium complex in persons with prior TB. In Abstracts of 1995 International Conference of the American Thoracic Society, Seattle, 1995, p 666
41. C.R. Horsburgh J.A. Havlik D.A. Ellis Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy Am Rev Respir Dis 144 1991 557
42. C.R. Horsburgh R.M. Selik The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS) Am Rev Respir Dis 139 1989 4
43. D. Huminer S. Dux Z. Samra Mycobacterium simiae infection in Israeli patients with AIDS Clin Infect Dis 17 1993 508
44. J.V. Iralu V.K. Srithatan W.S. Pieciak Diagnosis of Mycobacterium avium bacteremia by polymerase chain reaction J Clin Microbiol 31 1993 1811
45. Istrate N, Nochur SV: Latex agglutination assay for the identification of M. tuberculosis complex, M. avium complex and M. kansasii in culture. In Program and Abstracts of the 93rd General Meeting of the American Society for Microbiology, Washington, 1993, p 66
46. C.N. Jacob S.S. Henein A.E. Heurich Nontuberculous mycobacterial infection of the central nervous system in patients with AIDS South Med J 86 1993 638
47. M.A. Jacobson P.C. Hopewell D.M. Yajko Natural history of disseminated Mycobacterium avium complex infection in AIDS J Infect Dis 164 1991 994
48. R.C. Kalayjian Z. Toossi J.F. Tomashefski Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS Clin Infect Dis 20 1995 1186
49. J.E. Kaplan USPHS/IDSA Prevention of Opportunistic Infections Working Group USPHS/IDSA guideline for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations Clin Infect Dis 21 1995 S32
50. Keiser P, Rademacher S: G-CSF use is associated with prolonged survival in HIV infected patients with disseminated Mycobacterium avium complex infection. In Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, 1996, p 88
51. C.A. Kemper D. Havlir D. Haghighat The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS J Infect Dis 170 1994 157
52. A.D. Killian T.P. Kanyok G.L. Drusano Pharmacokinetics of drugs used for the therapy of Mycobacterium avium -complex infection J.A. Korvick C.A. Benson Mycobacterium avium -Complex Infection 1996 Marcel Dekker New York 197
53. B. Levine R.E. Chaisson Mycobacterium kansasii : A cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection Ann Intern Med 114 1991 861
54. C. Li M.J. Scuba L. Crane Mycobacterium kansasii sinusitis in a patient with AIDS Clin Infect Dis 19 1994 792
55. M. Lillo S. Orengo P. Cernoch Pulmonary and disseminated infection due to Mycobacterium kansasii : A decade of experience Rev Infect Dis 12 1990 760
56. H. Masur Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients with the human immunodeficiency virus N Engl J Med 329 1993 898
57. R.D. Moore R.E. Chaisson Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS AIDS 9 1995 1337
58. F. Moreno P.K. Sharkey-Mathis E. Mokulis Mycobacterium kansasii pericarditis in patients with AIDS Clin Infect Dis 19 1994 967
59. A.B. Morrisey T. Aisu J.O. Falkinham Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda J Acquir Immune Defic Syndr 5 1992 477
60. S.D. Nightingale L.T. Byrd P.M. Southern Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus–positive patients J Infect Dis 165 1992 1082
61. S.D. Nightingale D.W. Cameron F.M. Gordin Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS N Engl J Med 329 1993 828
62. D.O. Okello N. Sewankambo R. Goodgame Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS J Infect Dis 162 1990 208
63. Oldfield EC, Dickinson G, Chung R, et al: Once weekly azithromycin for the prevention of Mycobacterium avium complex infection in AIDS patients. In Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections, Washington, 1996, p 90
64. R.L. Owen R.I. Roth R.J. St. Hilaire Pseudo Whipple's disease—intestinal infection with Mycobacterium avium-intracellulare in AIDS Gastroenterology 84 1983 1267
65. M. Pechere M. Opravil A. Wald Clinical and epidemiologic features of infection with Mycobacterium genavense Arch Intern Med 155 1995 400
66. M. Pierce S. Crampton D. Henry A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome N Engl J Med 335 1996 384
67. M. Salfinger E.W. Stool D. Piot Comparison of three methods for recovery of Mycobacterium avium complex from blood specimens J Clin Microbiol 26 1988 1225
68. J.W. Sanders A.D. Walsh R.L. Snider Disseminated Mycobacterium scrofulaceum infection: A potentially treatable complication of AIDS Clin Infect Dis 20 1995 549
69. R.W. Shafer M.F. Sierra Mycobacterium xenopi , Mycobacterium fortuitum , Mycobacterium kansasii , and other nontuberculous mycobacteria in an area of endemicity for AIDS Clin Infect Dis 15 1992 161
70. S.D. Shafran J. Singer D.P. Zarowny A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol and clarithromycin versus rifampin, ethambutol, clofazamine and ciprofloxacin N Engl J Med 335 1996 377
71. J.P. Sison Y. Yao C.A. Kemper Treatment of Mycobacterium avium complex infection: Do the results of in vitro susceptibility tests predict therapeutic outcome in humans? J Infect Dis 173 1996 677
72. W.L. Straus S.M. Ostroff D.B. Jernigan Clinical and epidemiologic characteristics of Mycobacterium haemophilum , an emerging pathogen in immunocompromised patients Ann Intern Med 120 1994 118
73. P.M. Sullam F.M. Gordin B.A. Wynne Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex Clin Infect Dis 19 1994 84
74. E. Tortoli M.T. Simonetti C. Lacchini Tentative evidence of AIDS associated biotype of Mycobacterium kansasii J Clin Microbiol 32 1994 1779
75. G.T. Valainis L.M. Cardona D.L. Greer The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients J Acquir Immune Defic Syndr 4 1991 516
76. C.F. von Reyn J.N. Maslow T.W. Barber Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS Lancet 343 1994 1137
77. R.J. Wallace D. Dunbar B. Brown Rifampin-resistant Mycobacterium kansasii Clin Infect Dis 18 1994 736
78. R.S. Witzig B.A. Fazal R.M. Mera Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type I Clin Infect Dis 21 1995 77
79. G.L. Woods Disease due to the Mycobacterium avium complex in patients infected with human immunodeficiency virus: Diagnosis and susceptibility testing Clin Infect Dis 18 1994 S227 S232
80. D.M. Yajko D.P. Chin P.C. Gonzalez Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals J Acquir Immune Defic Syndr 9 1995 176
81. D.M. Yajko P.S. Nassos C.A. Sanders High predictive value of the acid-fast smear for Mycobacterium tuberculosis despite the high prevalence of Mycobacterium avium complex in respiratory specimens Clin Infect Dis 19 1994 334
82. L.S. Young L. Wiviott M. Wu Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS Lancet 338 1991 1107
83. P. Zakowski S. Fligiel O.G.W. Berlin Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency JAMA 248 1982 2980
84. M. Zaugg M. Salfinger M. Opravil Extrapulmonary and disseminated infections due to Mycobacterium malmoense : Case report and review Clin Infect Dis 16 1993 540